Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension

Pulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases. The presence of PH in the setting of underlying Interstitial Lung Disease (ILD) is strongly associated with decreased exercise and functional capacity, an increased risk of hospitalizations and death. Examining t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikkho, Sylvia M., Richter, Manuel J., Shen, Eric, Abman, Steven H., Antoniou, Katerina, Chung, Jonathan, Fernandes, Peter, Hassoun, Paul, Lazarus, Howard M., Olschewski, Horst, Piccari, Lucilla, Psotka, Mitchell, Saggar, Rajan, Shlobin, Oksana A., Stockbridge, Norman, Vitulo, Patrizio, Vizza, Carmine Dario, Wort, Stephen J., Nathan, Steven D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395696/
https://www.ncbi.nlm.nih.gov/pubmed/36016668
http://dx.doi.org/10.1002/pul2.12127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395696/
https://www.ncbi.nlm.nih.gov/pubmed/36016668
http://dx.doi.org/10.1002/pul2.12127

Ejemplares similares